Paige in the news
January 14, 2020

Invicro and Paige Partner to Offer Comprehensive Tissue Biomarker Profiling Services

BOSTON & NEW YORK--(BUSINESS WIRE)--Invicro LLC, a Konica Minolta Company and Paige, Inc., the leader in computational pathology, today announced a strategic alliance to provide integrated pathology solutions to support Pharmaceutical and Biotechnology sponsors with their drug discovery and development initiatives. Invicro is a global provider of imaging biomarkers, core lab services, advanced analytics and software solutions for drug discovery and development. Paige is a pioneer in transforming the diagnosis and treatment of cancer through clinical-grade artificial intelligence (AI).

Read More
January 10, 2020

Paige Welcomes Marty Chavez to our board of directors

Chavez joins Paige's board after recently retiring from Goldman Sachs, where he served 19 years in multiple roles – including CIO, CFO, and Co-Head of Securities. He's been credited as one of the key figures in elevating the roles of engineering and data science, both at Goldman Sachs and in the financial services sector more broadly. In this hands-on role at Paige, he will be working with the Company to help create a similar transformation in healthcare.

Read More
December 18, 2019

Paige Raises $45 Million to Accelerate the Future of Pathology

Paige, the leader in computational pathology transforming the diagnosis and treatment of cancer, today announced it has closed its Series B funding round of $45 million, bringing the Company’s total capital raised to over $70 million. Paige will use this new capital to drive FDA clearance of its products and expand its portfolio, delving deeper into cancer pathology, novel biomarkers and prognostic capabilities.

Read More
December 05, 2019

Philips and Paige team up to bring Artificial Intelligence (AI) to clinical pathology diagnostics

Amsterdam, The Netherlands – Royal Philips ( (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Paige, a leader in computational pathology, announced today a strategic collaboration to deliver clinical-grade AI applications to pathology laboratories. These AI technologies, starting with Paige Prostate, aim to help pathologists identify, quantify and characterize cancer in tissue samples and make precise diagnoses more efficiently. This may, ultimately, positively impact pathologist’s workflow and treatment planning for patients.

Read More
November 12, 2019

Paige announces first ever CE Mark for Deep Learning in Pathology

Paige has achieved CE mark for two products: Paige Prostate, a clinical-grade AI solution for cancer detection in prostate needle biopsies, and Insight, our AI-native viewer that primary diagnosis that Pathologists can use to perform diagnosis on images, supported by AI results across their workflow.

Read More
October 03, 2019

Paige is named as one of CB Insights most promising digital health startups

In addition to listing Paige as one of their most promising startups, CB Insights highlights Paige as one of the leaders in the transformation of pathology through artificial intelligence.

Read More
July 15, 2019

The technology we are bringing to clinics around the world: the First Clinical-Grade Artificial Intelligence in Pathology

Article Published in Nature Medicine Provides Further Scientific Evidence for Deployment of Computational Decision Support Systems to Improve Patient Care.

Go to Article arrow_forwards
May 15, 2019

Paige.AI Ramps Up Cancer Pathology Research Using NVIDIA Supercomputer

With the help of NVIDIA technology, Paige.AI is able to train deep neural networks from hundreds of thousands of gigapixel images of whole slides.

Go to Article arrow_forwards
April 24, 2019

A Real PAIGE-Turner

Revolutionizing cancer diagnostics through computational power – exploring the ultimate ambitions of the Pathology Artificial Intelligence Guidance Engine.

Go to Article arrow_forwards
March 07, 2019

FDA Grants Breakthrough Designation to Paige.AI

Expedites Product Development and Provides Priority Regulatory Review For Paige.AI’s Pioneering Clinical-Grade Artificial Intelligence in Pathology.

Go to Article arrow_forwards
February 18, 2019

Dr. Leo Grady joins Paige.AI as CEO and member of Board

Dr. Leo Grady is a seasoned healthcare technology leader with more than 15 years of experience in prototyping, developing, and bringing to market some of the industry’s most advanced machine learning, computer vision, and medical imaging technologies and products.

Go to Article arrow_forwards
February 13, 2019

Paige.AI Founder, Thomas Fuchs, featured amongst the "Top 100 AI Leaders in Drug Discovery and Advanced Healthcare.”

Dr. Leo Grady is a seasoned healthcare technology leader with more than 15 years of experience in prototyping, developing, and bringing to market some of the industry’s most advanced machine learning, computer vision, and medical imaging technologies and products.

Go to Article arrow_forwards
February 13, 2019

Paige.AI Founder Presents at SPIE Medical Imaging Conference 2019!

The conference is where the latest information is presented by leading researchers in image processing, physics, computer-aided diagnosis, perception, image-guided procedures, biomedical applications, ultrasound, informatics, radiology and digital pathology.

Go to Article arrow_forwards
February 06, 2019

Paige.AI is featured in the CB Insights' 2019 list of 100 most promising AI startups!

The CB Insights research team selected the 100 startups from a pool of 3K+ companies based on several factors, including patent activity, investor profile, news sentiment analysis, proprietary Mosaic scores, market potential, partnerships, competitive landscape, team strength, and tech novelty.

Go to Article arrow_forwards
January 16, 2019

Igneous Partners with Paige.AI To Enhance Industry Leading Compute Cluster for Healthcare AI

Through its partnership with Igneous, Paige.AI will be able to securely and efficiently manage 8 petabytes (PB) of unstructured data as part of an integrated machine learning-based healthcare AI workflow.

Go to Article arrow_forwards
May 21, 2018

Paige.AI Wins the Crain's New York Heritage Research Investigators in Translational Medicine Award

Thomas Fuchs of Paige.AI wins the Crain’s New York Heritage Research Investigators in Translational Medicine Award. Our team is humbled and inspired by this recognition!

Go to Article arrow_forwards
May 14, 2018

With Training, Startups Like Paige.AI Could Soon Diagnose Cancer

Xconomy discusses the future applications of AI in cancer diagnosis, featuring Paige.AI's founder, Thomas Fuchs.

Go to Article arrow_forwards
April 01, 2018

Paige.AI Forms One of the Largest Compute Clusters in Pathology and Healthcare, Enabling Deep Learning at Remarkable New Scale

Our high-performance computer cluster is built on the AIRI, a high performance, fully integrated software and hardware solution by Pure Storage and NVIDIA.

Go to Article arrow_forwards
March 26, 2018

Paige.AI Presents at Global Audience of Machine Learning Experts

At GTC 2018, one of the largest gatherings around AI and machine learning, our founder, Thomas Fuchs, spoke about the importance of harnessing technology to augment human ingenuity, particularly in Pathology.

Go to Article arrow_forwards
October 06, 2017

Plenary Talk and Panel at the 24th Prostate Cancer Foundation Scientific Retreat

Artificial Intelligence and Genomic were center stage at the 24th Prostate Cancer Foundation Scientific Retreat. PAIGE's Founder Thomas Fuchs gave a plenary talk on Computational Pathology and participated in a panel discussion about how the potential of AI can be realized in prostate cancer research.

Go to Article arrow_forwards
October 01, 2017

Launch of the Warren Alpert Center for Digital and Computational Pathology

The Warren Alpert Center for Digital and Computational Pathology at MSKCC was established in 2017 as an innovation center to facilitate novel research and development in digital pathology and computational pathology for clinical cancer care and research. Paige.AI's founder Thomas Fuchs serves as center director for Computational Pathology.

Go to Article arrow_forwards
July 06, 2017

How AI detectives are cracking open the black box of deep learning

Science produced a beautiful video explaining the inner workings of deep neural networks and how to open the black box, based on a paper by Jason Yosinski and our CSO Thomas Fuchs.

Go to Article arrow_forwards
June 27, 2017

A Reality Check for IBM's AI Ambitions

Paige.AI's founder gave an interview about the challenges of AI in medicine in general and in Computational Pathology in particular.

Go to Article arrow_forwards
May 09, 2017

NVIDIA's AI in Healthcare Summit 2017

Paige.AI's founder, Thomas, was invited to speak at NVIDIA's GTC AI in Healthcare Summit.

Go to Article arrow_forwards

How does Paige work?

Learn about our technology and how Paige is revolutionizing pathology.

About Paige